PXD070419 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | T-cell derived exosomes released from Multi-Core Granules exhibit potent caspase 3 mediated tumor suppressive activity ( Part II) |
| Description | Small extracellular vesicles (sEV) derived from cytotoxic T lymphocytes (CTLs) are emerging as potential mediators of antitumor immunity, yet their subcellular origins and functional properties remain incompletely defined. In this study, we investigated the intracellular routes and cytotoxic potential of CTL-derived sEVs. Using correlative light and electron microscopy, we discovered that CTL-derived sEVs are exosomes, as they originate from both the classical multivesicular bodies (MVBs) and the recently identified multicore granules (MCGs). Applying total internal reflection fluorescence microscopy, we revealed that, in contrast to MVB-derived exosomes, MCG-derived exosomes are released at the immunological synapse in a stimulus-dependent manner. To enable functional characterization, we developed a scalable primary cell culture method for the isolation of high-purity exosomes. Super-resolution microscopy demonstrated significant heterogeneity in exosome size and tetraspanin composition. Notably, MCG-derived exosomes demonstrated five times higher cytotoxic activity than MVB-derived exosomes, inducing apoptosis in tumor cells via a caspase-3-dependent mechanism. These findings reveal that CTLs exploit distinct secretory pathways to release heterogeneous exosome populations with differential cytotoxic capacities, offering new insights into CTL-mediated immune responses and providing a basis for the development of novel exosome-based immunotherapies |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-02-23 |
| AnnouncementXML | Submission_2026-02-22_17:33:54.765.xml |
| DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD070419 |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Supported dataset by repository |
| PrimarySubmitter | Claudia Fecher-Trost |
| SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: NEWT:10090; |
| ModificationList | acetylated residue; monohydroxylated residue; deamidated residue; iodoacetamide derivatized residue |
| Instrument | timsTOF Pro 2 |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-11-06 13:33:20 | ID requested | |
| ⏵ 1 | 2026-02-22 17:33:55 | announced | |
Publication List
| 10.6019/PXD070419; |
| Alawar N, Schirra C, Rasuli R, Fecher-Trost C, Weins L, Meyer MR, Flockerzi V, Keller A, Dustin ML, Rettig J, Becherer U, T-Cell-Derived Exosomes From Multi Core Granules Exhibit Superior Caspase-3-Mediated Tumor-Suppressive Activity Compared to Those From Multivesicular Bodies. J Extracell Vesicles, 15(2):e70239(2026) [pubmed] |
| 10.1002/jev2.70239; |
Keyword List
| submitter keyword: tetraspanins, 10x-expansion, Munc13-4, extracellular vesicles,primary cells, CD8+ T-cells, immunological synapse, multivesicular bodies |
Contact List
| Ute Becherer |
| contact affiliation | Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421 Homburg, Germany |
| contact email | Ute.Becherer@uks.eu |
| lab head | |
| Claudia Fecher-Trost |
| contact affiliation | PZMS |
| contact email | claudia.fecher-trost@uks.eu |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/02/PXD070419 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD070419
- Label: PRIDE project
- Name: T-cell derived exosomes released from Multi-Core Granules exhibit potent caspase 3 mediated tumor suppressive activity ( Part II)